Faculty of Medicine

Organisational unit: Faculty

More filtering options
  1. Treatment plan comparison using grading analysis based on clinical judgment.

    Kristoffer Petersson, Jacob Engellau, Per Nilsson, Per Engström, Tommy Knöös & Crister Ceberg, 2013, In : Acta Oncologica. 52, 3, p. 645-651

    Research output: Contribution to journalArticle

  2. Treatment potential for cholesterol management in patients with coronary heart disease in 15 European countries: Findings from the EUROASPIRE II survey

    K Kotseva, Martin Stagmo, D De Bacquer, G De Backer & D Wood, 2008, In : Atherosclerosis. 197, 2, p. 710-717

    Research output: Contribution to journalArticle

  3. Treatment process and outcome for long-term mentally ill patients in a comprehensive treatment program based on cognitive therapy

    Bengt Svensson, 1999, Div. of Psychiatry, Dept. of Clinical Neuroscience, University Hospital, SE-221 85, Lund, Sweden,. 142 p.

    Research output: ThesisDoctoral Thesis (compilation)

  4. Treatments and Mortality Trends in Cases With and Without Dialysis Who Have an Acute Myocardial Infarction: An 18-Year Nationwide Experience

    Karolina Szummer, Lars Lindhagen, Marie Evans, Jonas Spaak, Sasha Koul, Axel Åkerblom, Juan Jesus Carrero & Tomas Jernberg, 2019, In : Circulation. Cardiovascular Quality and Outcomes. 12, 9, e005879.

    Research output: Contribution to journalArticle

  5. Treatments for all RP-patients?

    Sten Andréasson, 2010, In : Acta Ophthalmologica. 88, p. 127

    Research output: Contribution to journalPublished meeting abstract

  6. Treatment strategy, disease activity, and outcome in four cohorts of patients with early rheumatoid arthritis

    J.M.C. Albers, L. Paimela, P. Kurki, Kerstin Eberhardt, P. Emery, M.A. van't Hof, F.H.J.M. Schreuder, M. Leirisalo-Repo & P.L.C.M. van Riel, 2001, In : Annals of the Rheumatic Diseases. 60, 5, p. 453-458

    Research output: Contribution to journalArticle

  7. Treatments with losartan or enalapril are equally sensitive to deterioration in renal function from cyclooxygenase inhibition.

    Tord Juhlin, Leif RW Erhardt, Helene Ottosson, Bo A Jönsson & Peter Höglund, 2007, In : European Journal of Heart Failure. 9, 2, p. 191-196

    Research output: Contribution to journalArticle

  8. Treatment (Tx) patterns and overall survival (OS) in patients (pts) with NSCLC in Sweden: A SCAN-LEAF study analysis from the I-O Optimise initiative

    S. Ekman, J. B. Sørensen, O. T. Brustugun, P. Horvat, D. Patel, M. Rosenlund, A. Mette Kejs, A. Juarez-Garcia, M. Daumont, L. Lacoin, J. R. Penrod, J. C. O'Donnell & M. Planck, 2019 Apr, In : Annals of Oncology. 30, Suppl 2, p. ii17 1 p.

    Research output: Contribution to journalPublished meeting abstract

  9. Treatment with a GnRH analogue: effects on hemostatic risk factors for thrombo-embolic disease

    C Lindoff, F Petersson, Göran Samsioe & B Astedt, 1994, In : International Journal of Fertility and Menopausal Studies. 39, 3, p. 133-139

    Research output: Contribution to journalArticle

  10. Treatment with AMD3100 attenuates the microglial response and improves outcome after experimental stroke.

    Helene L Walter, Gerlinde van der Maten, Ana Antunes, Tadeusz Wieloch & Karsten Ruscher, 2015, In : Journal of Neuroinflammation. 12, 24, p. 1-15

    Research output: Contribution to journalArticle

  11. Treatment with anti-factor VIIa in acute pancreatitis in rats: Blocking both coagulation and inflammation?

    Ellen Andersson, Jakob B Axelsson, Lars Christian Pedersen, Torben Elm & Roland Andersson, 2007, In : Scandinavian Journal of Gastroenterology. 42, 6, p. 765-770

    Research output: Contribution to journalArticle

  12. Treatment with apo B peptide vaccines inhibits atherosclerosis in human apo B-100 transgenic mice without inducing an increase in peptide-specific antibodies.

    Gunilla Nordin Fredrikson, Harry Björkbacka, Ingrid Söderberg, Irena Ljungcrantz & J Nilsson, 2008, In : Journal of Internal Medicine. 264, p. 563-570

    Research output: Contribution to journalArticle

  13. Treatment with a topical glucocorticoid, budesonide, reduced the variability of rhinomanometric nasal airway resistance

    Helle L. Thulesius, Anders Cervin & Max Jessen, 2014, In : Rhinology. 52, 1, p. 19-24

    Research output: Contribution to journalArticle

  14. Treatment with belimumab in SLE does not alter antobody response to 13-valent pneumococcal vaccine

    Johanna Nagel, Tore Saxne, Pierre Geborek, Anders Bengtsson, S Jacobsen, Svaerke Joergensen C, Jan-Åke Nilsson, Lillemor Skattum, Andreas Jönsen & Meliha C Kapetanovic, 2017, In : Lupus. 26, 10, p. 1072-1081

    Research output: Contribution to journalArticle

  15. Treatment with curative intent and survival in men with high-risk prostate cancer. A population-based study of 11 380 men with serum PSA level 20-100 ng/mL.

    Sam Ladjevardi, Anders Berglund, Eberhard Varenhorst, Ola Bratt, Anders Widmark & Gabriel Sandblom, 2013, In : BJU International. 111, 3, p. 381-388

    Research output: Contribution to journalArticle

  16. Treatment with direct oral anticoagulants in patients with upper extremity deep vein thrombosis

    Francisco Sánchez Montiel, Raein Ghazvinian, Anders Gottsäter & Johan Elf, 2017 Oct 3, In : Thrombosis Journal. 15, 1, 26.

    Research output: Contribution to journalArticle

  17. Treatment with laquinimod reduces development of active MRI lesions in relapsing MS

    C Polman, F Barkhof, Magnhild Sandberg Wollheim, A Linde, O Nordle & T Nederman, 2005, In : Neurology. 64, 6, p. 987-991

    Research output: Contribution to journalArticle